Literature DB >> 12570059

Intra-osseous soft tissue perineurioma of the inferior alveolar nerve.

A W Barrett1, C Hopper, G Landon.   

Abstract

This report describes an intra-osseous perineurioma affecting the inferior alveolar nerve, the second at this site, of a 53-year-old man. It produced a well defined, partially corticated, round radiolucency associated with resorption of the root apices of 36 and 37. Histology showed a circumscribed, partially encapsulated cellular tumour composed of bland spindle cells with undulating nuclei and indistinct cell membranes arranged in interlacing fascicles. The tumour was strongly positive for epithelial membrane antigen, collagen IV and laminin, with only scattered S100-positive cells and lack of CD34 expression. Electron microscopy showed elongated cells with continuous external laminae of basement membrane-like material, subplasmalemmal densities, desmosome-like junctions, and variable numbers of micropinocytotic vesicles. The lesion was surgically excised and in 9 months there has been no recurrence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12570059     DOI: 10.1016/s1368-8375(02)00005-2

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  3 in total

1.  Extraneural sclerosing perineurioma of the buccal mucosa: a case report and clinicopathologic review.

Authors:  Vikki L Noonan; David J Greene; Gilbert Brodsky; Sadru P Kabani
Journal:  Head Neck Pathol       Date:  2010-04-03

Review 2.  Intraoral perineurioma, soft tissue type: report of five cases, including 3 intraosseous examples, and review of the literature.

Authors:  Ioannis G Koutlas; Bernd W Scheithauer; Andrew L Folpe
Journal:  Head Neck Pathol       Date:  2010-04-17

Review 3.  Intraosseous intraneural perineurioma derived from the inferior alveolar nerve with an abnormality of chromosome 22 and expression of the BCR-ABL fusion gene: report of a case and review of recent literature.

Authors:  Jun Kurihara; Satoshi Yokoo; Miku Ichikawa; Takahiro Shimizu; Masaru Ogawa; Mai Seki
Journal:  World J Surg Oncol       Date:  2018-09-13       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.